Business Standard

Dabur India recovers 4% from day's low, trades 2% up despite weak Q4 nos

As the lockdown restrictions eased gradually, Dabur has been at the forefront of delivering authentic Ayurvedic solutions to meet the emerging Health Care needs of consumers in the post-COVID market.

Dabur
Premium

The management said that the impact of Covid-19 in the current quarter i.e. April-June (Q1FY21) revenue from operations is likely to be in the range of Rs 400-450 crore.

SI Reporter Mumbai
Shares of Dabur India moved higher by 2 per cent to Rs 439, recovering nearly 4 per cent from the day's low on the BSE on Thursday, despite weak earnings for the quarter ended March 2020 (Q4FY20) on value buying. In the past five weeks, the stock of personal products company has underperformed the market by falling 15 per cent, as compared to a 1 per cent rise in the S&P BSE Sensex.

The stock of Dabur India was down 2 per cent in the early morning deal after it reported a sharp 12 per cent year-on-year (YoY) decline in revenues

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in